01789 AK MEDICAL
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 3.65X | Oper Margin | 23.8% |
|---|---|---|---|
| LT Debt/Equity | 1.0% | Net Margin | 20.4% |
| Total Debt/Equity | 3.8% | Return on Equity | 10.4% |
| Price/Book | 2.32X | Return on Assets | 8.2% |
| (HKD 5.790) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 291.32 | 200.72 | 229.59 | 113.28 | 372.66 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +45.1 | -12.6 | +102.7 | -69.6 | +24.9 |
| Earnings Per Share (HKD) | 0.261 | 0.18 | 0.207 | 0.102 | 0.338 |
| Earnings Per Share Growth (%) | +44.8 | -12.9 | +103.3 | -69.9 | +18.0 |
| Dividend Per Share (HKD) | 0.072 | 0.045 | 0.060 | 0.025 | 0.040 |
| P/E* (X) | 22.18 | 32.11 | 27.97 | 56.88 | 17.13 |
| Yield (%) | 1.24 | 0.78 | 1.04 | 0.43 | 0.69 |
| Dividend Share (%) | 27.58 | 24.96 | 28.99 | 24.56 | 11.83 |
| Book NAV (HKD) | 2.499 | 2.350 | 2.255 | 2.227 | 2.173 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,346 | 1,094 | +23.0 | 1,052 |
| Operating Result | 319.822 | 231.117 | +38.4 | 240.29 |
| Profit Before Taxation | 319.822 | 231.117 | +38.4 | 240.29 |
| Taxation | 45.896 | 49.013 | -6.4 | 35.518 |
| Profit /( Loss) After Taxation | 273.926 | 182.104 | +50.4 | 204.772 |
| Net Profit | 273.926 | 182.104 | +50.4 | 204.772 |
| Earnings Per Share () | 0.2611 | 0.1803 | +44.8 | 0.2070 |
| Dividend Per Share () | 0.0720 | 0.0450 | +60.0 | 0.0600 |
| Announcement Date | 2025-03-26 | 2024-03-26 | NA | 2023-03-27 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
